Table 1. SHIV-RT infected animals that were used for the in vivo DARPin applications.
| DARPin treatment | Animal ID* | Baseline CD4 count (cells/µl) | Baseline plasma RNA viral load (copies/ml) |
| 300µg/kg 57.2 | HM17 | 734 | 9,500 |
| HM30 | 781 | 9,000 | |
| HM37 | 131 | 170,000 | |
| HM24 | 170 | 130,000 | |
| HM28 | 972 | <30 | |
| HM36 | 617 | 540,000 | |
| 30µg/kg 57.2 | HM20 | 1102 | 40 |
| HM26 | 190 | 19,000 | |
| GT61 | 800 | 120 | |
| 300µg/kg E3_5 | HM36 | 802 | 240,000 |
| HM27 | 293 | 120,000 | |
| HM28 | 1233 | 30 | |
| HM30 | 982 | 18,000 |
*3 animals are listed twice, because they were treated with the two DARPins on separate occasions.